Medtronic Return on Tangible Equity 2010-2025 | MDT
Medtronic Return On Tangible Equity Historical Data | |||
---|---|---|---|
Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
2025-04-30 | $4.66B | $-5.15B | -97.39% |
2025-01-31 | $4.26B | $-3.39B | -95.78% |
2024-10-31 | $4.29B | $-4.87B | -99.40% |
2024-07-31 | $3.93B | $-5.74B | -100.55% |
2024-04-30 | $3.68B | $-3.79B | -102.23% |
2024-01-31 | $4.20B | $-2.85B | -110.61% |
2023-10-31 | $4.10B | $-3.23B | -93.47% |
2023-07-31 | $3.62B | $-4.50B | -78.97% |
2023-04-30 | $3.76B | $-4.60B | -87.97% |
2023-01-31 | $4.06B | $-5.21B | -102.48% |
2022-10-31 | $4.32B | $-4.02B | -112.54% |
2022-07-31 | $5.21B | $-3.26B | -120.22% |
2022-04-30 | $5.04B | $-3.38B | -95.95% |
2022-01-31 | $4.91B | $-4.71B | -76.39% |
2021-10-31 | $4.70B | $-5.98B | -61.75% |
2021-07-31 | $3.88B | $-6.95B | -45.93% |
2021-04-30 | $3.61B | $-8.10B | -40.29% |
2021-01-31 | $2.89B | $-9.45B | -32.37% |
2020-10-31 | $3.54B | $-9.31B | -41.77% |
2020-07-31 | $4.41B | $-8.94B | -52.56% |
2020-04-30 | $4.79B | $-8.03B | -55.60% |
2020-01-31 | $5.32B | $-7.59B | -57.88% |
2019-10-31 | $4.67B | $-9.01B | -46.65% |
2019-07-31 | $4.42B | $-9.82B | -43.40% |
2019-04-30 | $4.63B | $-10.31B | -45.39% |
2019-01-31 | $4.92B | $-10.90B | -48.05% |
2018-10-31 | $2.26B | $-9.71B | -21.70% |
2018-07-31 | $3.16B | $-9.90B | -30.05% |
2018-04-30 | $3.10B | $-10.44B | -28.47% |
2018-01-31 | $2.81B | $-11.63B | -25.08% |
2017-10-31 | $5.02B | $-10.12B | -39.29% |
2017-07-31 | $4.12B | $-11.42B | -27.85% |
2017-04-30 | $4.03B | $-11.59B | -24.96% |
2017-01-31 | $3.97B | $-17.94B | -22.91% |
2016-10-31 | $4.24B | $-18.15B | -24.87% |
2016-07-31 | $3.65B | $-16.85B | -21.84% |
2016-04-30 | $3.54B | $-16.34B | -21.61% |
2016-01-31 | $2.43B | $-16.88B | -15.08% |
2015-10-31 | $2.32B | $-16.74B | -22.71% |
2015-07-31 | $2.62B | $-15.55B | -58.03% |
2015-04-30 | $2.68B | $-15.40B | 291.47% |
2015-01-31 | $3.12B | $6.88B | 48.74% |
2014-10-31 | $2.91B | $5.98B | 46.28% |
2014-07-31 | $2.98B | $6.21B | 48.04% |
2014-04-30 | $3.07B | $6.56B | 50.68% |
2014-01-31 | $3.59B | $6.39B | 61.57% |
2013-10-31 | $3.81B | $5.67B | 70.45% |
2013-07-31 | $3.56B | $5.57B | 68.71% |
2013-04-30 | $3.47B | $5.67B | 69.69% |
2013-01-31 | $3.49B | $4.74B | 74.36% |
2012-10-31 | $3.44B | $4.73B | 74.00% |
2012-07-31 | $3.66B | $4.76B | 82.45% |
2012-04-30 | $3.62B | $4.53B | 84.62% |
2012-01-31 | $3.40B | $4.54B | 83.57% |
2011-10-31 | $3.39B | $3.92B | 91.56% |
2011-07-31 | $3.09B | $4.10B | 85.00% |
2011-04-30 | $3.10B | $3.72B | 87.71% |
2011-01-31 | $3.28B | $3.07B | 93.07% |
2010-10-31 | $3.18B | $3.63B | 85.98% |
2010-07-31 | $3.48B | $3.70B | 98.22% |
2010-04-30 | $3.10B | $3.68B | 95.34% |
2010-01-31 | $2.25B | $3.80B | 75.92% |
2009-10-31 | $2.11B | $3.01B | 75.69% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $118.558B | $33.537B |
Medtronic, Inc. acquired Ireland-based Covidien plc. The acquisition resulted in the formation of a new holding company incorporated in Ireland - Medtronic plc. The company currently generates revenues from four major segments - namely Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience Portfolio and Diabetes. The Cardiovascular Portfolio, formerly reported as the Cardiac and Vascular Group, includes the Cardiac Rhythm & Heart Failure, Structural Heart & Aortic and Coronary & Peripheral Vascular divisions. The Medical Surgical Portfolio, formerly reported as the Minimally Invasive Therapies Group, includes the Surgical Innovations and the Respiratory, Gastrointestinal & Renal divisions. Neuroscience consists of Cranial & Spinal Technologies, Specialty The Neuroscience Portfolio, formerly reported as the Restorative Therapies Group, includes the Cranial & Spinal Technologies, Specialty Therapies, and Neuromodulation divisions. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $222.716B | 26.12 |
Boston Scientific (BSX) | United States | $157.517B | 37.62 |
Stryker (SYK) | United States | $152.893B | 31.97 |
EssilorLuxottica (ESLOY) | France | $140.240B | 0.00 |
Lonza Group Ag (LZAGY) | Switzerland | $50.586B | 0.00 |
Haleon (HLN) | United Kingdom | $44.070B | 25.15 |
ResMed (RMD) | United States | $40.718B | 30.58 |
GE HealthCare Technologies (GEHC) | United States | $35.587B | 16.90 |
Agilent Technologies (A) | United States | $34.042B | 22.19 |
Koninklijke Philips (PHG) | Netherlands | $26.981B | 17.85 |
Terumo (TRUMY) | Japan | $25.673B | 33.35 |
Insulet (PODD) | United States | $20.514B | 80.52 |
Zimmer Biomet Holdings (ZBH) | United States | $18.786B | 12.06 |
Baxter (BAX) | United States | $14.800B | 11.05 |
Smith & Nephew SNATS (SNN) | United Kingdom | $13.840B | 0.00 |
Sunny Optical Technology (SNPTF) | China | $10.417B | 0.00 |
Demant (WILYY) | Denmark | $8.633B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $6.874B | 23.92 |
Lantheus Holdings (LNTH) | United States | $4.995B | 12.60 |
Perrigo (PRGO) | Ireland | $3.859B | 9.78 |
Prestige Consumer Healthcare (PBH) | United States | $3.689B | 16.48 |
Haemonetics (HAE) | United States | $3.629B | 16.53 |
Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
Envista Holdings (NVST) | United States | $3.441B | 28.59 |
ICU Medical (ICUI) | United States | $3.119B | 23.00 |
LeMaitre Vascular (LMAT) | United States | $1.863B | 41.64 |
QuidelOrtho (QDEL) | United States | $1.720B | 11.83 |
AtriCure (ATRC) | United States | $1.571B | 0.00 |
Acuren (TIC) | United States | $1.369B | 0.00 |
Green Thumb Industries (GTBIF) | United States | $1.272B | 28.62 |
AdaptHealth (AHCO) | United States | $1.259B | 12.78 |
Phibro Animal Health (PAHC) | United States | $1.135B | 14.51 |
BioLife Solutions (BLFS) | United States | $1.057B | 0.00 |
Neogen (NEOG) | United States | $1.048B | 16.66 |
Curaleaf Holdings (CURLF) | Canada | $0.933B | 0.00 |
InMode (INMD) | Israel | $0.905B | 9.11 |
Kestra Medical Technologies (KMTS) | United States | $0.847B | 0.00 |
Valneva SE (VALN) | France | $0.660B | 0.00 |
Maravai LifeSciences Holdings (MRVI) | United States | $0.632B | 0.00 |
Evolus (EOLS) | United States | $0.596B | 0.00 |
Tilray Brands (TLRY) | Canada | $0.581B | 0.00 |
Owens & Minor (OMI) | United States | $0.576B | 4.78 |
Surmodics (SRDX) | United States | $0.535B | 0.00 |
CeriBell (CBLL) | United States | $0.533B | 0.00 |
ZimVie (ZIMV) | United States | $0.524B | 23.81 |
SNDL (SNDL) | Canada | $0.384B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.322B | 11.83 |
SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.308B | 0.00 |
Quanterix (QTRX) | United States | $0.304B | 0.00 |
Sanuwave Health (SNWV) | United States | $0.298B | 0.00 |
Cresco Labs (CRLBF) | United States | $0.295B | 0.00 |
Cerus (CERS) | United States | $0.254B | 0.00 |
Aurora Cannabis (ACB) | Canada | $0.250B | 74.00 |
Biote (BTMD) | United States | $0.249B | 7.00 |
Viemed Healthcare (VMD) | United States | $0.247B | 20.87 |
Omeros (OMER) | United States | $0.245B | 0.00 |
OraSure Technologies (OSUR) | United States | $0.245B | 0.00 |
Brainsway (BWAY) | Israel | $0.224B | 59.15 |
Sanara MedTech (SMTI) | United States | $0.222B | 0.00 |
Verano Holdings (VRNOF) | United States | $0.217B | 0.00 |
Canopy Growth (CGC) | Canada | $0.209B | 0.00 |
Organigram Global (OGI) | Canada | $0.189B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.183B | 15.09 |
Exagen (XGN) | United States | $0.180B | 0.00 |
Vireo Growth (VREOF) | United States | $0.177B | 0.00 |
High Tide (HITI) | Canada | $0.175B | 0.00 |
TriSalus Life Sciences (TLSI) | United States | $0.164B | 0.00 |
TerrAscend (TSNDF) | Canada | $0.132B | 0.00 |
FitLife Brands (FTLF) | United States | $0.123B | 15.18 |
Jushi Holdings (JUSHF) | United States | $0.107B | 0.00 |
Jin Medical (ZJYL) | China | $0.100B | 0.00 |
MacroGenics (MGNX) | United States | $0.100B | 0.00 |
Fonar (FONR) | United States | $0.099B | 12.74 |
Quipt Home Medical (QIPT) | United States | $0.095B | 0.00 |
Oramed Pharmaceuticals (ORMP) | United States | $0.090B | 0.00 |
Safety Shot (SHOT) | United States | $0.081B | 0.00 |
Zynex (ZYXI) | United States | $0.075B | 0.00 |
Apyx Medical (APYX) | United States | $0.074B | 0.00 |
Veru (VERU) | United States | $0.072B | 0.00 |
InterCure (INCR) | Israel | $0.068B | 0.00 |
Agape ATP (ATPC) | $0.064B | 0.00 | |
ImmuCell (ICCC) | United States | $0.059B | 0.00 |
Cytosorbents (CTSO) | United States | $0.057B | 0.00 |
Modular Medical (MODD) | United States | $0.038B | 0.00 |
United-Guardian (UG) | United States | $0.037B | 12.92 |
Nephros (NEPH) | United States | $0.037B | 49.57 |
Rockwell Medical (RMTI) | United States | $0.035B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.021B | 0.00 |
INLIF (INLF) | $0.016B | 0.00 | |
Flora Growth (FLGC) | United States | $0.015B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
Senestech (SNES) | United States | $0.012B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.011B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.010B | 0.00 |
Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
Sharps Technology (STSS) | United States | $0.006B | 0.00 |
GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
Akanda (AKAN) | Canada | $0.002B | 0.00 |
InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |